Enhancement of gene transfer efficiency into human cancer cells by modification of retroviral vectors and addition of chemicals

Oncology Reports

Volumn 7, Issue 1, 2000, Pages 119-124

  Song, Jaejin ^b   Kim, Joo Hang ^a,b   Lee, Heuiran ^a,b   Kim, Eunhee ^b   Kim, Jaesung ^b   Park, Yong Serk ^b   Ahn, Joongbae ^a,b   Yoo, Nae Choon ^a,b   Roh, Jae Kyung ^a,b   Kim, Byung Soo ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Cationic liposome; Lipofectamine; Packaging cell line; Retroviral vector; Transduction efficiency

Indexed keywords

CATION EXCHANGE RESIN; LIPID; LIPOFECTAMINE; VIRUS ENVELOPE PROTEIN;

ANIMAL; ARTICLE; CELL STRAIN 3T3; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; METABOLISM; MOUSE; NEOPLASM; RETROVIRUS;

3T3 CELLS; ANIMALS; CATION EXCHANGE RESINS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIPIDS; MICE; NEOPLASMS; RETROVIRIDAE; VIRAL ENVELOPE PROTEINS;

EID: 0033628040     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.1.119     Document Type: Article

References (22)

1. Boris-Lawrie K and Temin HM: The retroviral vector-replication cycle and safety considerations for retrovirus-mediated gene therapy. Ann NY Acad Sci 716: 59-70, 1994.
2. Blaese RM, Culver KW, Miller AD, et al: T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270:475-480, 1995.
3. Roth JA, Nguyen D, Lawrence DD, et al: Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2: 985-991, 1996.
4. Coffin JM, Hughes SH and Varmus HE: Development and application of retroviral vectors. In: Retroviruses. Coffin JM, Hughes SH and Varmus HE (eds). Cold Spring Harbor, New York, pp437-473, 1997.
5. Miller AD, Miller DG, Garcia JV and Lynch CM: Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217: 581-599, 1993.
6. Coffin JM: Retroviridae: the viruses and their replication. In: Fields Virology. Fields BN, Knipe DM and Howley PM (eds). Lippincott, Philadelphia, pp1767-1847, 1996.
7. Miller AD and Rosman GJ: Improved retroviral vectors for gene transfer and expression. Bio Techniques 7: 980-990, 1989.
8. Morgenstern JP and Land H: Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587-3596, 1990.
9. Riviere I, Brose K and Mulligan RC: Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 92: 6733-6737, 1995.
10. Mulligan RC: The basic science of gene therapy. Science 260: 926-931, 1993.
11. Jolly D: Viral vector systems for gene therapy. Cancer Gene Ther 1: 51-64, 1994.
12. Crystal RG: Transfer of genes to humans: early lessons and obstacles to success. Science 270: 404-410, 1995.
13. Pensiero MN, Wysocki CA, Nader K and Kikuchi GE: Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum. Human Gene Ther 7: 1095-1101, 1995.
14. Kim YS, Lim HK, Kim JH and Min JS: Comparison of efficiency of infection of human cancer cell lines via retroviral vector system. J Korean Cancer Assoc 29: 1-10, 1997.
15. Miller AD: Cell-surface receptors for retroviruses and implications for gene transfer. Proc Natl Acad Sci USA 93: 11407-11413, 1996.
16. Lam JS, Reeves ME, Cowherd R, Rosenberg SA and Hwu P: Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope. Hum Gene Ther 7: 1415-1422, 1996.
17. Movassagh M, Desmyter C, Baillou C, et al. High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocol. Hum Gene Ther 9: 225-234, 1998.
18. Kavanaugh MP, Miller DG, Zhang W, et al: Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 91: 7071-7075, 1994.
19. O'Hara B, Johann SV, Klinger HP, et al: Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth Differ 1: 119-127, 1990.
20. Miller AD, Garcia JV, Suhr NV, Lynch CM, Wilson C and Eiden MV: Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 65: 2220-2224, 1991.
21. Pear WS, Nolan GP, Scott ML and Baltimore D: Production of high titer helper-free retroviruses by transcient transfection. Proc Natl Acad Sci USA 90: 8392-8396, 1993.
22. Kinsella T and Nolan GP: Episomal vectors rapidly and stably produce high-liter recombinant retrovirus. Hum Gene Ther 7: 1405-1413, 1996.